InvestorsHub Logo
Followers 39
Posts 2870
Boards Moderated 0
Alias Born 12/06/2003

Re: youssef post# 3201

Wednesday, 04/25/2018 8:49:43 AM

Wednesday, April 25, 2018 8:49:43 AM

Post# of 3443
Youssef,

I know idra very well I had 20000 in 1 account I sold 10000 and I was playing with the house money till last week I started buying weekly

I congratulate you on your good fortune but your success tells me nothing about the science, its true value and prospects for the future.

Certainly the funds opposing the merger as well as the Baker Brothers backing the merger are as likely to know as much about toll-like receptors as a monkey knows about the breeding and cultivation of bananas.

I sold the stock at 10 cents or 20 cents a share when the intellectual founder of the biotech was dragged out of his laboratory and forced to confront a hostile world with a nearly bankrupt company as CEO with no management experience after the widely hailed MBA former CEO fled the seemingly failing company.

Toll-like receptors: mammalian "taste receptors" for a smorgasbord of microbial invaders.

https://www.ncbi.nlm.nih.gov/pubmed/11834372

I don't know if the splendid scientist using resistance of cells to the antisense oligonucleotides for beneficial effect knew he was ringing the bell of the recently discovered toll-like receptors but he never told me as best I can recall. I have wondered since. I knew about the TLR's from their discovery by Chinese scientists in Zadaxin that was owned by SCLN, an American biotech never allowed to market its drug in the U.S. after it was caught leaking data from a clinical trial.

That is the science behind IDRA that matters to me. The merger of BCRX and IDRA would be a great boon to both companies in my opinion. I think it will probably never happen because the jackasses that manage funds usually rely on word from some obsolete expert that never hears the bell ring anymore.

Best, Terry